Hikma To List Global Depositary Receipts On DIFX

Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK), the multinational pharmaceuticals group, will tomorrow list Global Depository Receipts (“GDRs”) on the Dubai International Financial Exchange (“DIFX”).

The listing follows Hikma’s initial public offering (the “IPO”) of ordinary shares on the London Stock Exchange in November 2005. This is a secondary listing of existing shares and each GDR will represent two ordinary shares.

Samih Darwazah, Chairman and Chief Executive of Hikma, said: “We are very pleased to announce the listing of our GDRs on the DIFX, in line with our stated intention at the time of our IPO. Through this listing, we hope to reinforce our strong profile in our Middle East and North Africa markets and to gain better access to the diverse Middle East investor base.”